Ortho Clinical Diagnostics to Participate in the 4th Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary

Ortho Clinical Diagnostics (Nasdaq: OCDX) will participate in the 4th Annual Evercore ISI HealthCONx Conference on November 30, 2021, featuring a fireside chat at 3:30 PM ET. A live webcast and replay will be available on the company’s Investors page. Ortho is a leading in vitro diagnostics company, impacting over 800,000 patients daily with innovative testing solutions. The company has a rich history in diagnostics innovation, including groundbreaking HIV and COVID-19 tests.

RARITAN, N.J., Nov. 23, 2021 (GLOBE NEWSWIRE) --  Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, today announced that members of its management team are scheduled to participate in the 4^th Annual Evercore ISI HealthCONx Conference on Tuesday, November 30, 2021, with a fireside chat scheduled for 3:30pm ET.

Interested parties can access a live webcast and replay of the fireside chat on the “Investors” page of the company’s website at https://ir.orthoclinicaldiagnostics.com/, under the “Events” section of the page.

About Ortho Clinical Diagnostics

Ortho Clinical Diagnostics (Nasdaq: OCDX) is one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care.

More than 800,000 patients across the world are impacted by Ortho’s tests each day. Because Every Test Is A Life^TM, Ortho provides hospitals, hospital networks, clinical laboratories and blood banks around the world with innovative technology and tools to ensure test results are fast, accurate and reliable. Ortho's customized solutions enhance clinical outcomes, improve efficiency, overcome lab staffing challenges and reduce costs.

From launching the first product to determine Rh+ or Rh- blood type, developing the world’s first tests for the detection of antibodies against HIV and hepatitis C, introducing patented dry-slide technology, and marketing the first U.S. Food and Drug Administration-authorized high-volume antibody and antigen tests for COVID-19, Ortho has been a pioneering leader in the IVD space for over 80 years.

The company is powered by Ortho Care^® Service and Support, an award-winning, holistic program that ensures best-in-class technical, field, and remote service and inventory support to laboratories in more than 130 countries and territories around the globe.

For more information, visit Ortho’s social media channels: LinkedIn, Twitter, Facebook and YouTube. 

Investors:

IR@orthoclinicaldiagnostics.com

Media:

media@orthoclinicaldiagnostics.com

FAQ

When is Ortho Clinical Diagnostics participating in the Evercore ISI HealthCONx Conference?

Ortho Clinical Diagnostics will participate in the Evercore ISI HealthCONx Conference on November 30, 2021.

What time is the fireside chat at the Evercore ISI HealthCONx Conference?

The fireside chat is scheduled for 3:30 PM ET.

How can I watch the webcast of the fireside chat?

The webcast can be accessed live and replayed on the Investors page of Ortho Clinical Diagnostics' website.

What is the significance of Ortho Clinical Diagnostics in the healthcare industry?

Ortho Clinical Diagnostics is a major player in in vitro diagnostics, impacting over 800,000 patients daily with innovative testing technologies.